Medical - Devices
Compare Stocks
4 / 10Stock Comparison
MOVE vs FITB vs RF vs MNMD
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Biotechnology
MOVE vs FITB vs RF vs MNMD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Devices | Banks - Regional | Banks - Regional | Biotechnology |
| Market Cap | $810M | $34.06B | $24.49B | $2.04B |
| Revenue (TTM) | $500K | $13.05B | $9.61B | $0.00 |
| Net Income (TTM) | $-17M | $2.41B | $2.16B | $-184M |
| Gross Margin | -270.2% | 59.2% | 74.6% | — |
| Operating Margin | -31.6% | 22.3% | 28.5% | — |
| Forward P/E | — | 16.5x | 10.8x | — |
| Total Debt | $186K | $18.97B | $4.88B | $0.00 |
| Cash & Equiv. | $8M | $3.01B | $10.91B | $258M |
MOVE vs FITB vs RF vs MNMD — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| Movano Inc. (MOVE) | 100 | 1.6 | -98.4% |
| Fifth Third Bancorp (FITB) | 100 | 135.8 | +35.8% |
| Regions Financial C… (RF) | 100 | 136.5 | +36.5% |
| Mind Medicine (Mind… (MNMD) | 100 | 45.2 | -54.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MOVE vs FITB vs RF vs MNMD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MOVE lags the leaders in this set but could rank higher in a more targeted comparison.
FITB carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 15 yrs, beta 1.09, yield 3.4%
- Rev growth 5.6%, EPS growth -2.5%
- Lower volatility, beta 1.09, Low D/E 96.6%, current ratio 0.38x
- Beta 1.09, yield 3.4%, current ratio 0.38x
RF is the #2 pick in this set and the best alternative if long-term compounding and bank quality is your priority.
- 284.7% 10Y total return vs MNMD's 5.1%
- NIM 3.1% vs FITB's 2.6%
- Better valuation composite
- 22.4% margin vs MOVE's -34.1%
MNMD is the clearest fit if your priority is momentum.
- +227.9% vs RF's +41.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.6% NII/revenue growth vs MNMD's -64.9% | |
| Value | Better valuation composite | |
| Quality / Margins | 22.4% margin vs MOVE's -34.1% | |
| Stability / Safety | Beta 1.09 vs MOVE's 1.98 | |
| Dividends | 3.4% yield, 15-year raise streak, vs RF's 3.7%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +227.9% vs RF's +41.3% | |
| Efficiency (ROA) | 1.4% ROA vs MOVE's -306.8% |
MOVE vs FITB vs RF vs MNMD — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
MOVE vs FITB vs RF vs MNMD — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
RF leads in 3 of 6 categories
MNMD leads 1 • MOVE leads 0 • FITB leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
RF leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
FITB and MNMD operate at a comparable scale, with $13.0B and $0 in trailing revenue. RF is the more profitable business, keeping 22.4% of every revenue dollar as net income compared to MOVE's -34.1%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $500,000 | $13.0B | $9.6B | $0 |
| EBITDAEarnings before interest/tax | -$16M | $3.6B | $2.8B | -$156M |
| Net IncomeAfter-tax profit | -$17M | $2.4B | $2.2B | -$184M |
| Free Cash FlowCash after capex | -$14M | $3.4B | $2.1B | -$161M |
| Gross MarginGross profit ÷ Revenue | -2.7% | +59.2% | +74.6% | — |
| Operating MarginEBIT ÷ Revenue | -31.6% | +22.3% | +28.5% | — |
| Net MarginNet income ÷ Revenue | -34.1% | +17.7% | +22.4% | — |
| FCF MarginFCF ÷ Revenue | -27.1% | +18.5% | +22.7% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | +60.0% | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +53.0% | +16.7% | +3.6% | -22.0% |
Valuation Metrics
RF leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 12.3x trailing earnings, RF trades at a 24% valuation discount to FITB's 16.2x P/E. On an enterprise value basis, RF's 6.6x EV/EBITDA is more attractive than FITB's 14.7x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $810M | $34.1B | $24.5B | $2.0B |
| Enterprise ValueMkt cap + debt − cash | $802M | $50.0B | $18.5B | $1.8B |
| Trailing P/EPrice ÷ TTM EPS | -34.49x | 16.19x | 12.32x | -10.04x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 16.50x | 10.79x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.71x | — |
| EV / EBITDAEnterprise value multiple | — | 14.66x | 6.58x | — |
| Price / SalesMarket cap ÷ Revenue | 799.74x | 2.61x | 2.55x | — |
| Price / BookPrice ÷ Book value/share | 110.15x | 1.78x | 1.30x | 5.56x |
| Price / FCFMarket cap ÷ FCF | — | 14.13x | 11.23x | — |
Profitability & Efficiency
RF leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
FITB delivers a 11.4% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-4 for MOVE. MOVE carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to FITB's 0.97x. On the Piotroski fundamental quality scale (0–9), RF scores 9/9 vs MNMD's 3/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -4.4% | +11.4% | +11.3% | -55.3% |
| ROA (TTM)Return on assets | -3.1% | +1.1% | +1.4% | -41.8% |
| ROICReturn on invested capital | — | +5.7% | +8.5% | -3.9% |
| ROCEReturn on capital employed | -4.3% | +7.0% | +9.6% | -52.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 9 | 3 |
| Debt / EquityFinancial leverage | 0.03x | 0.97x | 0.26x | — |
| Net DebtTotal debt minus cash | -$8M | $16.0B | -$6.0B | -$258M |
| Cash & Equiv.Liquid assets | $8M | $3.0B | $10.9B | $258M |
| Total DebtShort + long-term debt | $186,000 | $19.0B | $4.9B | $0 |
| Interest CoverageEBIT ÷ Interest expense | -10.38x | 0.75x | 1.32x | -14.63x |
Total Returns (Dividends Reinvested)
MNMD leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in RF five years ago would be worth $14,374 today (with dividends reinvested), compared to $169 for MOVE. Over the past 12 months, MNMD leads with a +227.9% total return vs RF's +41.3%. The 3-year compound annual growth rate (CAGR) favors MNMD at 82.7% vs MOVE's -58.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +53.2% | +7.4% | +3.3% | +51.7% |
| 1-Year ReturnPast 12 months | +47.8% | +43.1% | +41.3% | +227.9% |
| 3-Year ReturnCumulative with dividends | -92.8% | +126.3% | +90.0% | +510.3% |
| 5-Year ReturnCumulative with dividends | -98.3% | +37.7% | +43.7% | -59.6% |
| 10-Year ReturnCumulative with dividends | -98.6% | +253.2% | +284.7% | +512.1% |
| CAGR (3Y)Annualised 3-year return | -58.4% | +31.3% | +23.9% | +82.7% |
Risk & Volatility
Evenly matched — FITB and MNMD each lead in 1 of 2 comparable metrics.
Risk & Volatility
FITB is the less volatile stock with a 1.09 beta — it tends to amplify market swings less than MOVE's 1.98 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MNMD currently trades 98.1% from its 52-week high vs MOVE's 38.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.98x | 1.09x | 1.10x | 1.68x |
| 52-Week HighHighest price in past year | $34.87 | $55.44 | $31.53 | $21.09 |
| 52-Week LowLowest price in past year | $4.67 | $36.55 | $20.67 | $6.03 |
| % of 52W HighCurrent price vs 52-week peak | +38.6% | +91.7% | +89.5% | +98.1% |
| RSI (14)Momentum oscillator 0–100 | 44.5 | 55.4 | 53.8 | 64.9 |
| Avg Volume (50D)Average daily shares traded | 70K | 8.3M | 11.9M | 806K |
Analyst Outlook
Evenly matched — FITB and RF each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MOVE as "Buy", FITB as "Buy", RF as "Hold", MNMD as "Buy". Consensus price targets imply 11.1% upside for FITB (target: $57) vs -3.3% for MNMD (target: $20). For income investors, RF offers the higher dividend yield at 3.67% vs FITB's 3.37%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $56.50 | $30.78 | $20.00 |
| # AnalystsCovering analysts | 4 | 51 | 52 | 1 |
| Dividend YieldAnnual dividend ÷ price | — | +3.4% | +3.7% | — |
| Dividend StreakConsecutive years of raises | — | 15 | 13 | — |
| Dividend / ShareAnnual DPS | — | $1.71 | $1.04 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.8% | +4.4% | 0.0% |
RF leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). MNMD leads in 1 (Total Returns). 2 tied.
MOVE vs FITB vs RF vs MNMD: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MOVE or FITB or RF or MNMD a better buy right now?
For growth investors, Fifth Third Bancorp (FITB) is the stronger pick with 5.
6% revenue growth year-over-year, versus 2. 5% for Regions Financial Corporation (RF). Regions Financial Corporation (RF) offers the better valuation at 12. 3x trailing P/E (10. 8x forward), making it the more compelling value choice. Analysts rate Movano Inc. (MOVE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MOVE or FITB or RF or MNMD?
On trailing P/E, Regions Financial Corporation (RF) is the cheapest at 12.
3x versus Fifth Third Bancorp at 16. 2x. On forward P/E, Regions Financial Corporation is actually cheaper at 10. 8x.
03Which is the better long-term investment — MOVE or FITB or RF or MNMD?
Over the past 5 years, Regions Financial Corporation (RF) delivered a total return of +43.
7%, compared to -98. 3% for Movano Inc. (MOVE). Over 10 years, the gap is even starker: MNMD returned +512. 1% versus MOVE's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MOVE or FITB or RF or MNMD?
By beta (market sensitivity over 5 years), Fifth Third Bancorp (FITB) is the lower-risk stock at 1.
09β versus Movano Inc. 's 1. 98β — meaning MOVE is approximately 81% more volatile than FITB relative to the S&P 500. On balance sheet safety, Movano Inc. (MOVE) carries a lower debt/equity ratio of 3% versus 97% for Fifth Third Bancorp — giving it more financial flexibility in a downturn.
05Which is growing faster — MOVE or FITB or RF or MNMD?
By revenue growth (latest reported year), Fifth Third Bancorp (FITB) is pulling ahead at 5.
6% versus 2. 5% for Regions Financial Corporation (RF). On earnings-per-share growth, the picture is similar: Movano Inc. grew EPS 38. 1% year-over-year, compared to -1273. 3% for Mind Medicine (MindMed) Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MOVE or FITB or RF or MNMD?
Regions Financial Corporation (RF) is the more profitable company, earning 22.
4% net margin versus -23. 4% for Movano Inc. — meaning it keeps 22. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RF leads at 28. 5% versus -23. 9% for MOVE. At the gross margin level — before operating expenses — RF leads at 74. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MOVE or FITB or RF or MNMD more undervalued right now?
On forward earnings alone, Regions Financial Corporation (RF) trades at 10.
8x forward P/E versus 16. 5x for Fifth Third Bancorp — 5. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FITB: 11. 1% to $56. 50.
08Which pays a better dividend — MOVE or FITB or RF or MNMD?
In this comparison, RF (3.
7% yield), FITB (3. 4% yield) pay a dividend. MOVE, MNMD do not pay a meaningful dividend and should not be held primarily for income.
09Is MOVE or FITB or RF or MNMD better for a retirement portfolio?
For long-horizon retirement investors, Regions Financial Corporation (RF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
10), 3. 7% yield, +284. 7% 10Y return). Movano Inc. (MOVE) carries a higher beta of 1. 98 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (RF: +284. 7%, MOVE: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MOVE and FITB and RF and MNMD?
These companies operate in different sectors (MOVE (Healthcare) and FITB (Financial Services) and RF (Financial Services) and MNMD (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MOVE is a small-cap quality compounder stock; FITB is a mid-cap deep-value stock; RF is a mid-cap deep-value stock; MNMD is a small-cap quality compounder stock. FITB, RF pay a dividend while MOVE, MNMD do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.